CompletedPhase IOther

Phase I trial: MM-120-101

The MM-120-101 study is an early-stage clinical trial involving healthy volunteers. Early trials, known as Phase 1 studies, are essential for testing how a potential new medicine behaves in the human body and checking for side effects. At present, the full details about the medicine and study procedures are not public. The UK Health Research Authority (HRA), which protects the rights and safety of research participants in the UK, has formally approved keeping these details private for a set time. This often happens in early research to protect confidential scientific information. Full study details will be released to the public record within 30 months after the study ends. Even with deferred publication, all Phase 1 trials in the UK must follow strict safety, ethics, and regulatory standards to protect everyone who takes part.

At a glance

Status

Completed

Phase

Phase I

Sponsor

Mind Medicine Inc

Enrolment target

Start

13 Oct 2023

Estimated completion

04 Dec 2023

Healthy volunteers

What is this study about?

Phase 1 trials are the very first step in testing a potential new treatment in people. The main goal of study MM-120-101 is to evaluate safety, see how the body handles the study medicine, and look out for any unwanted side effects. Testing new treatments in healthy volunteers first gives scientists a clear baseline before trying the treatment in people with specific illnesses.

You might notice that specific details about what this study tests are not listed. The Health Research Authority (HRA), the UK body that oversees research ethics and safety, has granted a 'deferral of publication'. This is a formal permission that allows researchers to keep the exact scientific details private for a limited time, usually to protect intellectual property or commercial research.

Even though the public description is currently withheld, the study has still undergone rigorous ethical and scientific review. All clinical trials carried out in the UK must follow very strict laws designed to keep participants safe. Full details of the trial will be added to the public register within 30 months after the study wraps up.

Key takeaways

MM-120-101 is an early Phase 1 safety trial designed for healthy volunteers.
The Health Research Authority has approved keeping the specific study details confidential for now.
Full trial information will be published within 30 months of the study's completion.
Phase 1 trials focus on checking safety, finding proper doses, and watching for side effects.
Participation is always voluntary, and you can withdraw at any time.

Who may be eligible?

Because the full information for this study is currently confidential, the exact checklist of who can and cannot join has not been made public.

In general, Phase 1 studies looking for 'healthy volunteers' invite adults who are in good overall health. They usually look for people who do not have long-term medical conditions and who are not taking regular prescription medicines.

If you are interested in taking part in early research like this, the clinical research unit running the study can provide the full list of entry rules. They will review your medical history carefully to make sure taking part is safe for you.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

You consider yourself to be in good general health.
You do not have major long-term health conditions.
You are not taking regular prescription medicines.
You are willing to stay overnight at a clinical research centre if required.
You are happy to undergo health checks, such as blood tests and heart scans.

Answer every question to see your result.

What does participation involve?

In a typical Phase 1 healthy volunteer study, taking part involves several clear steps. First, you attend a screening visit where doctors check your overall health through blood tests, heart traces (ECGs), and physical checks. If you are eligible, you may need to stay at a specialist clinical research unit for a set number of days and nights so the medical team can monitor you closely. During the stay, you receive the study treatment, and the team regularly checks your blood, blood pressure, and general wellbeing. After leaving the clinic, there are usually short follow-up visits or phone calls to ensure you have recovered well. The exact schedule and duration for this specific trial will be explained directly by the research team before you agree to join.

Potential risks and benefits

Because this is an early-stage study, the medicine may cause side effects that doctors do not yet fully know about. Common temporary discomforts can include bruising from blood tests or feeling tired or sick after taking the treatment. Healthy volunteers do not receive any direct medical benefit or cure from taking part, though they receive a thorough health check-up and often receive payment to cover their time and travel expenses. Taking part is completely voluntary, and you are free to leave the trial at any point without giving a reason.

Locations (2)

Some site locations are approximate. We're improving this — please verify with the trial team before travelling.

MAC Clinical Research Liverpool
City only
Liverpool, England
MAC Clinical Research Manchester
City only
Manchester, England

Common questions

Why are the details of this study kept secret?

The UK Health Research Authority has allowed the details to remain private for now, which is common in early research to protect new scientific discoveries before they are patented.

Is the study still safe if the details are not public?

Yes. The trial must still meet all strict UK safety laws and be approved by an independent research ethics committee before any volunteer can join.

When will the results and details be shared?

All details and findings must be published on the public trial registry within 30 months after the study ends.

Do healthy volunteers get paid for taking part?

Phase 1 trials in the UK usually offer financial compensation to healthy volunteers to cover their time, inconvenience, and travel costs.

Can I leave the study if I change my mind?

Yes, you can leave any clinical trial at any time. Your safety and comfort always come first, and you do not need to give a reason.

How to find out more

David Gregory

davidgregory@macplc.com +44 (0)151 4824700 Official trial record

Always speak to your GP or specialist before deciding to take part in a study.